Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis
Cells convey information among one another. One instrument employed to transmit data and constituents to specific (target) cells is extracellular vesicles (EVs). They originate from a variety of cells (endothelial, immune cells, platelets, mesenchymal stromal cells, etc.), and consequently, their su...
Main Authors: | Adriana Georgescu, Maya Simionescu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/11/5967 |
Similar Items
-
Platelet extracellular vesicles as biomarkers for arterial thrombosis
by: Aleksandra Gasecka, et al.
Published: (2017-04-01) -
Extracellular vesicles as biomarkers and modulators of atherosclerosis pathogenesis
by: Sarvatit Patel, et al.
Published: (2023-05-01) -
Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis
by: Vitor H. Almeida, et al.
Published: (2019-07-01) -
Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence
by: Konstantinos Zifkos, et al.
Published: (2021-08-01) -
Extracellular Vesicles in Atherosclerosis: State of the Art
by: Wioletta Olejarz, et al.
Published: (2023-12-01)